Articles

A prospective, observational, multicentre study to evaluate the efficacy of brivaracetam as adjuvant therapy for epilepsy: The Bravo study

Fowzia Siddiqui, Bashir A Soomro, Ehsan U Rehman, Ahsan Numan, Safia Bano, Jawwad Us Salam, Hazim Brohi, Muhammad Zaheer, Faizan Hyder Memon, Muhammad Wahab Qureshi, Junaid Ahmed Sheikh, Abdul Latif Sunejo, Amjad Iqbal, Saira Abbass, Saba Zaidi, Sidrah Nawaz, Kaukab Fatima, Samar Altaf, Neeta Maheshwary, Muhammad Athar Khan, Arjumand Ahmed, Muhammad Iqbal Asif

Article Type

Original Research

Published

The objective of this study was to assess the effectiveness of Brivera when used as an adjunctive therapy for individuals diagnosed with epilepsy.

Read more

Effect of norethisterone dose and duration in the management of abnormal uterine bleeding: a narrative review and case report

Arun Madhab Boruah, Dibyendu Banerjee, Farendra Bhardwaj, Subash Mallya, Rajat Singal, Sugandha Sharma, Ashutosh Gautam

Article Type

Review

Published

The present review summarizes the epidemiology and diagnosis of abnormal uterine bleeding, with a focus on the safety, efficacy and tolerability of norethisterone/norethisterone acetate in abnormal uterine bleeding management, as well as a case of abnormal uterine bleeding in a 40-year-old woman, who was treated with NETA tablets.

Read more

Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study

Jesús Calleja-Escudero, Víctor Barrondo, Andrés Rodriguez-Alonso, Francisco Gómez-Veiga, Joan Bestard, Antonio Gómez-Caamaño, Anne-Sophie Grandoulier, Maria Pérez-Sampietro, Venancio Chantada-Abal, Raúl Poza de Celis, on behalf of ANAREN Study Group

Article Type

Original Research

Published

This study aims to determine the percentage of patients whose initial luteinizing hormone-releasing hormone agonists prescription was renewed during follow-up, how many changed formulation and how their quality of life evolved.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.